Hemgenix has been specified ‘conditional authorisation’. Because of this the European Medicines Company decided that the key benefits of Hemgenix are better than its dangers, but the company must deliver extra proof soon after authorisation.When provided to the individual, the virus will carry the issue IX gene to the liver cells, enabling them